End-of-day quote
Buenos Aires S.E.
06:00:00 2023-09-03 pm EDT
|
5-day change
|
1st Jan Change
|
27
ARS
|
+1.89%
|
|
-.--%
|
-.--%
|
Fiscal Period: June |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
462
|
167.2
|
484
|
524.7
|
660
|
602.8
|
Enterprise Value (EV)
1 |
462.3
|
173.4
|
508.7
|
252.3
|
1,435
|
3,459
|
P/E ratio
|
35.3
x
|
11.7
x
|
8.83
x
|
7.51
x
|
0.94
x
|
-46.6
x
|
Yield
|
1.19%
|
4.61%
|
-
|
4%
|
8.17%
|
-
|
Capitalization / Revenue
|
1.34
x
|
0.17
x
|
0.27
x
|
0.16
x
|
0.12
x
|
0.06
x
|
EV / Revenue
|
1.34
x
|
0.17
x
|
0.28
x
|
0.08
x
|
0.25
x
|
0.35
x
|
EV / EBITDA
|
6.66
x
|
2.08
x
|
4.68
x
|
1.47
x
|
1.04
x
|
5.23
x
|
EV / FCF
|
-46.4
x
|
-1.39
x
|
1.51
x
|
0.76
x
|
-2.99
x
|
-1.1
x
|
FCF Yield
|
-2.16%
|
-72.2%
|
66.4%
|
131%
|
-33.5%
|
-91%
|
Price to Book
|
10.4
x
|
1.91
x
|
2.77
x
|
1.76
x
|
0.75
x
|
0.31
x
|
Nbr of stocks (in thousands)
|
22,000
|
22,000
|
22,000
|
22,000
|
22,000
|
22,000
|
Reference price
2 |
21.00
|
7.600
|
22.00
|
23.85
|
30.00
|
27.40
|
Announcement Date
|
6/11/18
|
6/14/19
|
7/17/20
|
6/9/21
|
9/9/22
|
9/11/23
|
Fiscal Period: June |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
344.7
|
993.6
|
1,812
|
3,206
|
5,734
|
9,767
|
EBITDA
1 |
69.41
|
83.29
|
108.7
|
171.3
|
1,382
|
661.4
|
EBIT
1 |
68.48
|
81.34
|
103.1
|
162.4
|
1,366
|
621.9
|
Operating Margin
|
19.86%
|
8.19%
|
5.69%
|
5.06%
|
23.83%
|
6.37%
|
Earnings before Tax (EBT)
1 |
21.41
|
32.16
|
87.01
|
110.7
|
1,069
|
283.6
|
Net income
1 |
13.1
|
14.27
|
54.81
|
69.88
|
694.1
|
-12.93
|
Net margin
|
3.8%
|
1.44%
|
3.03%
|
2.18%
|
12.1%
|
-0.13%
|
EPS
2 |
0.5956
|
0.6487
|
2.491
|
3.177
|
32.00
|
-0.5875
|
Free Cash Flow
1 |
-9.971
|
-125.2
|
337.5
|
331.2
|
-479.9
|
-3,149
|
FCF margin
|
-2.89%
|
-12.6%
|
18.63%
|
10.33%
|
-8.37%
|
-32.24%
|
FCF Conversion (EBITDA)
|
-
|
-
|
310.55%
|
193.35%
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
615.83%
|
473.93%
|
-
|
-
|
Dividend per Share
2 |
0.2500
|
0.3500
|
-
|
0.9530
|
2.452
|
-
|
Announcement Date
|
6/11/18
|
6/14/19
|
7/17/20
|
6/9/21
|
9/9/22
|
9/11/23
|
Fiscal Period: June |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
0.28
|
6.23
|
24.7
|
-
|
775
|
2,857
|
Net Cash position
1 |
-
|
-
|
-
|
272
|
-
|
-
|
Leverage (Debt/EBITDA)
|
0.003994
x
|
0.0748
x
|
0.2272
x
|
-
|
0.5606
x
|
4.319
x
|
Free Cash Flow
1 |
-9.97
|
-125
|
338
|
331
|
-480
|
-3,149
|
ROE (net income / shareholders' equity)
|
33.1%
|
21.6%
|
36%
|
25.5%
|
33.4%
|
-0.91%
|
ROA (Net income/ Total Assets)
|
9.68%
|
5.56%
|
3.53%
|
4.55%
|
8.68%
|
4.37%
|
Assets
1 |
135.3
|
256.9
|
1,554
|
1,538
|
7,992
|
-295.8
|
Book Value Per Share
2 |
2.020
|
3.980
|
7.950
|
13.50
|
40.00
|
89.10
|
Cash Flow per Share
2 |
0.1100
|
0.2100
|
0.1100
|
2.300
|
1.290
|
3.530
|
Capex
1 |
1.78
|
2.01
|
3.06
|
22.6
|
1.45
|
21.9
|
Capex / Sales
|
0.52%
|
0.2%
|
0.17%
|
0.7%
|
0.03%
|
0.22%
|
Announcement Date
|
6/11/18
|
6/14/19
|
7/17/20
|
6/9/21
|
9/9/22
|
9/11/23
|
|
1st Jan change
|
Capi.
|
---|
| -.--% | 670K | | +2.08% | 3.61B | | -19.91% | 2.15B | | -7.20% | 1.95B | | +2.34% | 1.9B | | +1.54% | 1.71B | | -3.83% | 1.3B | | +3.39% | 1.19B | | -18.55% | 1.06B | | +2.18% | 1.06B |
Pesticide
|